PHAR vs PRQR: Side-by-Side Comparison
Compare Pharming Group N.V. (PHAR) and ProQR Therapeutics N.V (PRQR) side by side: market cap USD 965.83M vs USD 190.71M. Financials, growth and model signals on Bullrun.
| Metric | PHAR | PRQR |
|---|---|---|
| Company | Pharming Group N.V. | ProQR Therapeutics N.V |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 965.83M | USD 190.71M |
| P/E ratio | 79.9 | — |
| Dividend yield | — | — |
| Valuation model | 37.6% overvalued | — |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |